Drug Shortage Report for RABEPRAZOLE EC

Last updated on 2023-12-01 History
Report ID 198918
Drug Identification Number 02356538
Brand name RABEPRAZOLE EC
Common or Proper name RABEPRAZOLE SODIUM
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 20MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 500
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-07-18
Estimated end date
Actual end date 2023-11-30
Shortage status Resolved
Updated date 2023-12-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2023-12-01 French Compare
v16 2023-12-01 English Compare
v15 2023-11-22 French Compare
v14 2023-11-22 English Compare
v13 2023-10-23 French Compare
v12 2023-10-23 English Compare
v11 2023-10-01 French Compare
v10 2023-10-01 English Compare
v9 2023-09-19 French Compare
v8 2023-09-19 English Compare
v7 2023-08-28 French Compare
v6 2023-08-28 English Compare
v5 2023-07-31 French Compare
v4 2023-07-31 English Compare
v3 2023-07-19 English Compare
v2 2023-07-18 French Compare
v1 2023-07-18 English Compare

Showing 1 to 17 of 17